Interview with Leopoldo Dimerin, President & General Manager, Otsuka…
You were appointed President and General Manager of Otsuka Philippines in 2008. Can you please start by giving to our readers an overview of Otsuka activities in the country as…
Address: 2129 King’s Court II Building Chino Roces Avenue, Makati City Philippines
Tel: +63 2 888-6774
Web: http://www.otsuka.com.ph/
Official operations of Otsuka (Philippines) Pharmaceutical, Inc. (OPPI) began January, 1998 with sixty-five employees, composed mainly of medical representatives deployed nationwide promoting Otsuka products namely Meptin (Procaterol), a bronchodilator; Mikelan (Carteolol), a beta-blocker; Aminoleban Injection and Aminoleban EN (Amino acids) for the treatment of hepatic encephalopathy and Nutritional supplement for liver failure patients; and Pletaal (Cilostazol) an antiplatelet agent.
Over the years of its incorporation, OPPI continues to grow despite many economic and political issues. In 2003, OPPI launched Mucosta (Rebamipide), a cytoprotective agent indicated for the treatment of gastritis and gastric ulcer. The following year, to address the concerns of many patients taking Aminoleban EN, Aminoleban ORAL was launched. Aminoleban Oral offers the same nutritional value as the Aminoleban EN, more affordable with palatable taste amino acid enteral solution.
In October 2005, OPPI launched its blockbuster antipsychotic drug Abilify (Aripiprazole). August 2006 marked the entry of Firebird, a drug eluting stent. OPPI has been continuously growing and in 2007 it entered the consumer market with its isotonic drink Pocari Sweat.
What started as a small division of Marsman & Drug, Inc. in 1985 to its establishment as Otsuka (Philippines) Pharmaceutical, Inc. in 1997, Otsuka Philippines proves that it can face the challenges in the pharmaceutical market, thus 2006 marked the Otsuka Rising!
Under the corporate philosophy of ‘Otsuka – people creating new products for better health worldwide,’ Otsuka Pharmaceutical Co., Ltd. is engaged in the production and sale of innovative, creative pharmaceuticals, nutritional products, and cosmetics, aiming to be a global value-creating company that contributes to the health and wellness of people worldwide.
You were appointed President and General Manager of Otsuka Philippines in 2008. Can you please start by giving to our readers an overview of Otsuka activities in the country as…
Tiziana Mele, managing director of Lundbeck Italia, explains the impact of COVID on mental health care from the perspective of a company dedicated to brain health, outlines the Italian operation…
Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known player may be Taiho Pharmaceutical, a Japanese specialty pharma player that was a pioneer in…
Japan’s pharma market is one of the world’s biggest, with a value of around USD 95 billion, according to figures from the country’s Ministry of Health, Labour and Welfare (MHLW).…
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the northerly fringe of the European Union all belie a legacy as a real…
Shinsuke Yuasa, president of Thai Otsuka discusses the importance of Thailand for Otsuka as its first overseas market back in 1973. Yuasa goes on to highlight how the affiliate is…
A relative newcomer to the Nordic countries, Otsuka has successfully built a strong foothold in the region. Pontus Billstam, managing director for the Nordics & Benelux, looks back at the…
Stewart Pearce, managing director of Otsuka UK and Ireland since 2017 discloses how he built up a leadership team fit for the Otsuka of 2023 and highlights what he appreciates…
Having managed the Canadian affiliate of Otsuka from its infancy steps, Allison Rosenthal, general manager, highlights the affiliate’s feat to exceed expectations for the performance of each of its launches…
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Thai Otsuka’s president explains the Otsuka Group’s commitment to Thailand, the tremendous potential they see in the market in light of the opening up of the ASEAN Economic Community and…
The managing director of Otsuka’s 50-50 joint venture with Turkish giant Abdi Ibrahim, Abdi Ibrahim Otsuka, discusses the mutual advantage the companies can offer each other, and branding Abdi Ibrahim…
You were appointed President and General Manager of Otsuka Philippines in 2008. Can you please start by giving to our readers an overview of Otsuka activities in the country as…
See our Cookie Privacy Policy Here
